Alnylam Pharmaceuticals, Inc.SEC Filings
|
|
All SEC filings by Alnylam Pharmaceuticals, Inc. (ALNY) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 30, 2026 | |
| 10-Q | Quarterly report | View Diff | Apr 30, 2026 | |
| ARS | Annual report to shareholders | Apr 6, 2026 | ||
| 10-K | Annual report | View Diff | Feb 12, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 30, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 31, 2025 | |
| 10-Q | Quarterly report | View Diff | May 1, 2025 | |
| ARS | Annual report to shareholders | Mar 24, 2025 | ||
| 10-K | Annual report | View Diff | Feb 13, 2025 | |
| 10-Q | Quarterly report | View Diff | Oct 31, 2024 |
Events
| 8-K | Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress | Jul 30, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | May 27, 2026 | ||
| 8-K | Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress | Apr 30, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Mar 4, 2026 | ||
| 8-K | Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress | Feb 12, 2026 | ||
| 8-K | Alnylam Launches “alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact | Jan 12, 2026 | ||
| 8-K | Alnylam Announces Partial Repurchase of 1.00% Convertible Senior Notes Due 2027 | Dec 11, 2025 | ||
| 8-K | Alnylam Pharmaceuticals Announces Changes to Board of Directors | Dec 3, 2025 | ||
| 8-K | Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress | Oct 30, 2025 | ||
| 8-K | Entry Into a Material Definitive Agreement | Oct 3, 2025 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | Feb 12, 2026 | ||
| S-8 | Registration of securities for employees | Feb 23, 2023 | ||
| S-8 | Registration of securities for employees | Feb 11, 2021 | ||
| S-3ASR | Automatic shelf registration | Jun 5, 2020 | ||
| S-8 | Registration of securities for employees | Feb 13, 2020 | ||
| 424B5 | Prospectus supplement for primary offering | Jan 15, 2019 | ||
| 424B5 | Prospectus supplement for primary offering | Jan 14, 2019 | ||
| S-8 POS | Registration of securities for employees (post-effective amendment) | Aug 2, 2018 | ||
| S-8 POS | Registration of securities for employees (post-effective amendment) | Aug 2, 2018 | ||
| S-8 POS | Registration of securities for employees (post-effective amendment) | Aug 2, 2018 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Apr 6, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 6, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 4, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 24, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 24, 2025 | |
| PRE 14A | Preliminary proxy | Mar 14, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | Apr 1, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 1, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Apr 3, 2023 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 3, 2023 |
Other
| UPLOAD | Letter from SEC | Jun 17, 2025 | ||
| CORRESP | Correspondence with SEC | May 22, 2025 | ||
| UPLOAD | Letter from SEC | May 9, 2025 | ||
| UPLOAD | Letter from SEC | Sep 25, 2024 | ||
| CORRESP | Correspondence with SEC | Aug 22, 2024 | ||
| UPLOAD | Letter from SEC | Aug 12, 2024 | ||
| CT ORDER | Confidential treatment order | Feb 14, 2023 | ||
| SEC STAFF | SEC staff action: Order | Mar 18, 2021 | ||
| SEC STAFF | SEC staff action: Order | Feb 18, 2021 | ||
| CT ORDER | Confidential treatment order | Jul 5, 2019 |
Ownership
| 4 | Pyott David E I | Jun 3, 2026 | ||
| 4 | Cravatt Benjamin | Jun 3, 2026 | ||
| 3 | Cravatt Benjamin | Jun 3, 2026 | ||
| 144 | Notice of proposed sale of securities | Jun 1, 2026 | ||
| 4 | Charles Elliott Sigal | May 22, 2026 | ||
| 4 | Amy W Schulman | May 22, 2026 | ||
| 4 | Colleen F Reitan | May 22, 2026 | ||
| 4 | David E I Pyott | May 22, 2026 | ||
| 4 | Peter N Kellogg | May 22, 2026 | ||
| 4 | Margaret a Hamburg | May 22, 2026 |